Wealthspire Advisors (Maryland)’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q3
Sell
-50
Closed 2673
2017
Q2
$0 Hold
50
﹤0.01% 2401
2017
Q1
$0 Hold
50
﹤0.01% 2132
2016
Q4
$0 Hold
50
﹤0.01% 1951
2016
Q3
$0 Buy
+50
New ﹤0.01% 1910
2016
Q2
Sell
-51
Closed 1947
2016
Q1
$0 Hold
51
﹤0.01% 2000
2015
Q4
$1K Buy
+51
New +$1K ﹤0.01% 1712